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Stent implantation for the treatment of coronary artery disease can cause unintended tearing at of vessel wall adjacent to the stent struts resulting in 
a stent edge dissection (SED). At present, limited data 
is available on the exact optical coherence tomography 
(OCT) characteristics of SEDs that might warrant further 
treatment. Given this background, we aimed to study the 
morphometric features and impact of untreated SEDs on 
clinical outcomes and assess dissection healing.
We retrospectively identified 295 untreated SEDs in 
261 patients from a dedicated local database containing 
all OCT recordings from January 2009 to August 2017. 
Patients were eligible in case they underwent a percuta-
neous coronary intervention with stent implantation and 
postprocedural OCT evaluation. SEDs were defined as 
tearing of the vessel luminal surface within 5 mm of the 
proximal or distal stent border. Selected pullbacks with 
untreated SEDs were quantitatively analyzed using dedi-
cated software (Rubo DICOM viewer 2.0; Rubo Medical 
Imaging, Aerdenhout, the Netherlands).
The plaque type at the site of the SED was catego-
rized into fibrous, fibroatheroma, lipid or necrotic core, 
superficial calcium, or deep calcium. The following mor-
phometric characteristics of each dissection were mea-
sured: longitudinal length, circumferential extension, 
cavity depth, maximal thickness of the dissection flap, 
minimal lumen area and area stenosis in the SED, dissec-
tion area and reference lumen area. The severity of each 
dissection was further characterized based on its extend 
to either subintimal or submedial and the presence of an 
intramural hematoma or thrombus.1 Finally, in the subset 
of 51 patients (53 SEDs) with follow-up OCT imaging, 
the presence of late persisting SEDs on OCT was evalu-
ated stratified per follow-up timeframe, (1–7 days, 7 
days–6 months, 6–12 months and >1 year). The primary 
end point of the study was a device-oriented compos-
ite end point (DOCE) at 1 year, defined as a composite 
of cardiac death, target lesion myocardial infarction, or 
target lesion revascularization. To evaluate independent 
predictors for DOCE at follow-up, all patients, vessel, and 
SED characteristics were first tested univariably using a 
Cox proportional hazards model, which accounted for the 
multilevel nature of the data. Subsequently, variables with 
a P<0.05 were inserted into the model. For the strati-
fied analysis of distal and proximal SEDs, only univariate 
hazard ratios were examined since not enough events 
occurred for a multivariable analysis. The data and ana-
lytical methods used in this study will be not made avail-
able. The study was approved by the institutional review 
committee of the Erasmus Medical Centre, and all sub-
jects gave informed consent.
The study population consisted of 71% males, 22% of 
the patients had diabetes mellitus, and 25% presented 
with an ST-segment–elevation myocardial infarction. The 
overall median SED length was 2.0±(1.4–3.0) mm with a 
median angle of 54±(34–92)º. The minimal lumen areas 
in the proximal and distal SEDs were 6.4±(4.5–8.3) mm2 
and 4.3±(3.1–5.8) mm2, respectively. Clinical follow-up 
was available for 89% of the patients, and at 1 year, the 
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length (adjusted hazard ratio, 1.17 [95% CI, 1.02–1.34]) 
was associated with an increased risk of DOCE. For 
distal SEDs, cavity depth in mm was the only predictor 
of 1-year DOCE (hazard ratio, 1.029 [95% CI, 1.012–
1.047]), whereas reference area in mm2 (adjusted hazard 
ratio, 0.63 [95% CI, 0.45–0.87]) was the only predictor 
for 1-year DOCE in patients with proximal SEDs (Figure).
Within the first week, postprocedure, all (8/8) of the 
SEDs were still visible on OCT. Between 1 week and 
6 months, SEDs remained visible in up to 15% (2/13), 
whereas between 6 and 12 months, 16% (3/19) were 
still visible. No remaining SEDs were visible after 1 year 
(median follow-up 22 months; 0/13).
The incidence of the DOCE in the present study 
was significantly lower as compared to previous studies 
reporting on the outcome of patients with SEDs.2–4 The 
latter might be due to an overall lower risk of the present 
study population and follow-up truncation at 1 year. The 
CLI-OPCI ACS (Clinical Impact of Suboptimal Stenting 
and Residual Intrastent Plaque/Thrombus Protrusion in 
Patients With Acute Coronary Syndrome) and CLI-OPCI 
II used an arbitrary cutoff for flap thickness of 0.20 mm 
and found this to be a significant predictor for DOCE.2,3 
In contrast, we found dissection length (best cut-off for 
DOCE at 3.55 mm) to be the only independent predictor 
of the DOCE at 1 year. Almost 85% of the SEDs were 
Figure. Independent morphometric predictors of device-oriented clinical end point (DOCE) at 1 y in patient with stent edge 
dissections detected by optical coherence tomography. 
Upper: Dissection length is an independent predictor for DOCE at 1 y in all stent edge dissections (SED), cross-section A and B refer to the 
corresponding location on the longitudinal view. The combination of highest sensitivity and specificity for SED length indicated that the best 
cut-off for DOCE at 1 y was at 3.55 mm (Youden index=0.22, area under the curve=0.56). D and P denote distal and proximal, respectively. 
Middle: Cavity depth is an independent predictor for DOCE at 1 y for distal SEDs, the cross-sections correspondent to the dashed line on 
the longitudinal view. Lower: Proximal reference lumen area is an independent predictor for DOCE at 1 y for proximal SEDs, cross-section A 
and B refer to the corresponding location on the longitudinal view. Cross-section B denotes the proximal reference lumen area in white. The red 
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no longer visible at 6 months, whereas after 1 year, none 
of them were still visible. The latter is in line with previ-
ous research reporting SEDs were still visible in 10% of 
cases at 12 months follow-up.5
In conclusion, this is the largest cohort of patients with 
SEDs to date, demonstrating a 6.7% risk of 1-year cardiac 
events potentially linked to untreated dissections. In patients 
with SEDs, dissection length, cavity depth, and proximal ref-
erence area were identified as predictors of the DOCE.
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